PLoS ONE (Jan 2021)

Delirium as a predictor of mortality and disability among hospitalized patients in Zambia.

  • Justin K Banerdt,
  • Kondwelani Mateyo,
  • Li Wang,
  • Christopher J Lindsell,
  • Elisabeth D Riviello,
  • Deanna Saylor,
  • Douglas C Heimburger,
  • E Wesley Ely

DOI
https://doi.org/10.1371/journal.pone.0246330
Journal volume & issue
Vol. 16, no. 2
p. e0246330

Abstract

Read online

ObjectiveTo study the epidemiology and outcomes of delirium among hospitalized patients in Zambia.MethodsWe conducted a prospective cohort study at the University Teaching Hospital in Lusaka, Zambia, from October 2017 to April 2018. The primary exposure was delirium duration over the initial 3 days of hospitalization, assessed daily using the Brief Confusion Assessment Method. The primary outcome was 6-month mortality. Secondary outcomes included 6-month disability, evaluated using the World Health Organization Disability Assessment Schedule 2.0.Findings711 adults were included (median age, 39 years; 461 men; 459 medical, 252 surgical; 323 with HIV). Delirium prevalence was 48.5% (95% CI, 44.8%-52.3%). 6-month mortality was higher for delirious participants (44.6% [39.3%-50.1%]) versus non-delirious participants (20.0% [15.4%-25.2%]; P ConclusionAmong hospitalized medical and surgical patients in Zambia, delirium prevalence was high and delirium duration independently predicted mortality and disability at 6 months. This work lays the foundation for prevention, detection, and management of delirium in low-income countries. Long-term follow up of outcomes of critical illness in resource-limited settings appears feasible using the WHO Disability Assessment Schedule.